Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor

Atherosclerosis

Volumn 181, Issue 2, 2005, Pages 251-259

  Wu, Kenneth K ^a   Wu, Tsuei Ju ^a   Chin, Jayne ^a   Mitnaul, Lyndon J ^a   Hernandez, Melba ^a   Cai, Tian Quan ^a   Ren, Ning ^a   Waters, M Gerard ^a   Wright, Samuel D ^a   Cheng, Kang ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Apoe ; Atherosclerosis; db db; Dyslipidemia; Fenofibrate; Hyperglycemia; Insulin resistant; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN E; FENOFIBRATE; LEPTIN; LEPTIN RECEPTOR;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; EVALUATION; FEMALE; GENE DELETION; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTILIPEMIC AGENTS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; FEMALE; HYPERCHOLESTEROLEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROCETOFEN; RECEPTORS, CELL SURFACE; SEVERITY OF ILLNESS INDEX;

EID: 22544470917     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.01.029     Document Type: Article

References (35)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285 (May (19)): 2486-2497.
2. B.V. Howard, B.L. Rodriguez, and P.H. Bennett Prevention conference VI: diabetes and cardiovascular disease. Writing group I: epidemiology Circulation 105 May (18) 2002 e132 e137
3. S. Fazio, and M.F. Linton Mouse models of hyperlipidemia and atherosclerosis Front Biosci 6 March 2001 D515 D525
4. B. Paigen, A.S. Plump, and E.M. Rubin The mouse as a model for human cardiovascular disease and hyperlipidemia Curr Opin Lipidol 5 1994 258 264
5. J.L. Breslow Mouse models of atherosclerosis Science 272 1996 685 688
6. V.V. Kunjathoor, D.L. Wilson, and R.C. LeBoeuf Increased atherosclerosis in streptozotocin-induced diabetic mice J Clin Invest 97 April (7) 1996 1767 1773
7. Y. Kako, M. Masse, L.S. Huang, A.R. Tall, and I.J. Goldberg Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice J Lipid Res 43 June (6) 2002 872 877
8. The Jackson Laboratory web site at: http://www.jax.org check stock number 000697.
9. The Jackson Laboratory web site at: http://www.jax.org check stock number 002052.
10. C.P. Sparrow, C.A. Burton, and M. Hernandez Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering Arterioscler Thromb Vasc Biol 21 January (1) 2001 115 121
11. L. Park, K.G. Raman, and K.J. Lee Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts Nat Med 4 September (9) 1998 1025 1031
12. K. Kobayashi, T.M. Forte, and S. Taniguchi The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding Metabolism 49 January (1) 2000 22 31
13. A.H. Hasty, H. Shimano, and J. Osuga Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor J Biol Chem 276 October (40) 2001 37402 37408
14. R.H. Eckel, M. Wassef, and A. Chait Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes Circulation 105 May (18) 2002 e138 e143
15. F. Peelman, W. Waelput, and H. Iserentant Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases Prog Lipid Res 43 July (4) 2004 283 301
16. M.R. Sierra-Honigmann, A.K. Nath, and C. Murakami Biological action of leptin as an angiogenic factor Science 281 September (5383) 1998 1683 1686
17. T. Gainsford, T.A. Willson, and D. Metcalf Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells Proc Natl Acad Sci U S A 93 December (25) 1996 14564 14568
18. A. Oda, T. Taniguchi, and M. Yokoyama Leptin stimulates rat aortic smooth muscle cell proliferation and migration Kobe J Med Sci 47 June (3) 2001 141 150
19. M. Nakata, T. Yada, N. Soejima, and I. Maruyama Leptin promotes aggregation of human platelets via the long form of its receptor Diabetes 48 1999 426 429
20. P.F. Bodary, R.J. Westrick, K.J. Wickenheiser, Y.C. Shen, and D.T. Eitzman Effect of leptin on arterial thrombosis following vascular injury in mice JAMA 287 2002 1706 1709
21. M.R. Sierra-Honigmann, A.K. Nath, and C. Murakami Biological action of leptin as an angiogenic factor Science 281 1998 1683 1686
22. K. Schafer, M. Halle, and C. Goeschen Leptin Promotes Vascular Remodeling and Neointimal Growth in Mice Arterioscler Thromb Vasc Biol 24 January (1) 2004 112 117
23. G.H. Lee, R. Proenca, and J.M. Montez Abnormal splicing of the leptin receptor in diabetic mice Nature 379 February (6566) 1996 632 635
24. W.I. Sivitz, S.A. Walsh, D.A. Morgan, M.J. Thomas, and W.G. Haynes Effects of leptin on insulin sensitivity in normal rats Endocrinology 138 August (8) 1997 3395 3401
25. M.A. Pelleymounter, M.J. Cullen, and M.B. Baker Effects of the obese gene product on body weight regulation in ob/ob mice Science 269 July (5223) 1995 540 543
26. H. Duez, Y.S. Chao, and M. Hernandez Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice J Biol Chem 277 December (50) 2002 48051 48057
27. H.B. Rubins, S.J. Robins, D. Collins Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol N Engl J Med 341 August (6) 1999 410 418
28. P. Delerive, J.C. Fruchart, and B. Staels Peroxisome proliferator- activated receptors in inflammation control J Endocrinol 169 June (3) 2001 453 459
29. M. Pascal, C. Sepulchre, J.B. Chazan, and B. Majoie Evidence for the inhibition of platelet-derived growth factor induced rat smooth muscle cells DNA synthesis by fenofibric acid at the Go/G1 cell cycle level Life Sci 33 September (10) 1983 925 933
30. H. Sano, T. Sudo, and M. Yokode Functional blockade of platelet-derived growth factor receptor-beta but not of receptor-alpha prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice Circulation 103 June (24) 2001 2955 2960
31. P. Boucher, M. Gotthardt, W.P. Li, R.G. Anderson, and J. Herz LRP: role in vascular wall integrity and protection from atherosclerosis Science 300 April (5617) 2003 329 332
32. M. Lassila, T.J. Allen, and Z. Cao Imatinib attenuates diabetes-associated atherosclerosis Arterioscler Thromb Vasc Biol 24 May (5) 2004 935 942 Epub 2004 Feb 26
33. F. Forcheron, A. Cachefo, S. Thevenon, C. Pinteur, and M. Beylot Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients Diabetes 51 December (12) 2002 3486 3491
34. G. Chinetti, S. Lestavel, and V. Bocher PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat Med 7 January (1) 2001 53 58
35. Y. Wang, and J.F. Oram Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1 J Biol Chem 277 February (7) 2002 5692 5697